Inclusion Criteria : 
   1.  Adults ≥  18 years old
   2.  High risk for cardiovascular morbidity and mortality such as prior history of clinical cardiovascular disease and / or history of familial hypercholesterolemia
   3.  LDL - C within the past  6 months above recommended level despite maximal tolerated statin therapy ± ezetimibe for the past  3 months . 
Exclusion Criteria : 
   1.  Current treatment with PCSK 9 inhibitor
   2.  Current participation in investigational study
   3.  Prior participation in the GOAL program